Concepts (70)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetic Nephropathies | 5 | 2022 | 114 | 1.180 |
Why?
|
| Podocytes | 5 | 2023 | 76 | 0.620 |
Why?
|
| Renal Insufficiency, Chronic | 3 | 2023 | 837 | 0.580 |
Why?
|
| Diabetes Mellitus | 1 | 2022 | 886 | 0.420 |
Why?
|
| Glucosides | 2 | 2026 | 54 | 0.390 |
Why?
|
| Benzhydryl Compounds | 2 | 2026 | 75 | 0.380 |
Why?
|
| Glycocalyx | 1 | 2026 | 5 | 0.240 |
Why?
|
| Centrosome | 1 | 2025 | 28 | 0.230 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 1 | 2025 | 31 | 0.230 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2026 | 642 | 0.210 |
Why?
|
| Genomic Instability | 1 | 2025 | 250 | 0.210 |
Why?
|
| Cryopyrin-Associated Periodic Syndromes | 1 | 2023 | 3 | 0.200 |
Why?
|
| Proteinuria | 2 | 2021 | 106 | 0.200 |
Why?
|
| Endothelium, Vascular | 1 | 2026 | 469 | 0.200 |
Why?
|
| HMGB1 Protein | 1 | 2023 | 28 | 0.190 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2023 | 129 | 0.190 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2023 | 145 | 0.190 |
Why?
|
| Glyoxylates | 1 | 2021 | 4 | 0.180 |
Why?
|
| Hyperoxaluria | 1 | 2021 | 6 | 0.180 |
Why?
|
| Kidney Glomerulus | 1 | 2021 | 80 | 0.170 |
Why?
|
| Growth Hormone | 1 | 2021 | 127 | 0.170 |
Why?
|
| Monocytes | 1 | 2022 | 337 | 0.170 |
Why?
|
| Ramipril | 1 | 2020 | 3 | 0.170 |
Why?
|
| Oximes | 1 | 2020 | 55 | 0.160 |
Why?
|
| Hepatocytes | 1 | 2021 | 234 | 0.160 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2020 | 1409 | 0.150 |
Why?
|
| Indoles | 1 | 2020 | 205 | 0.150 |
Why?
|
| Interleukin-1beta | 1 | 2019 | 159 | 0.140 |
Why?
|
| Cell Cycle | 1 | 2021 | 598 | 0.140 |
Why?
|
| Metformin | 1 | 2020 | 167 | 0.140 |
Why?
|
| Research Design | 1 | 2022 | 722 | 0.130 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2021 | 403 | 0.120 |
Why?
|
| Animals | 8 | 2026 | 34335 | 0.120 |
Why?
|
| Acute Kidney Injury | 1 | 2023 | 685 | 0.110 |
Why?
|
| Transcriptome | 1 | 2021 | 1162 | 0.110 |
Why?
|
| Epithelial Cells | 3 | 2023 | 900 | 0.100 |
Why?
|
| Mice | 7 | 2026 | 18470 | 0.100 |
Why?
|
| Antibodies, Monoclonal | 1 | 2019 | 1008 | 0.100 |
Why?
|
| Mitosis | 2 | 2025 | 190 | 0.100 |
Why?
|
| Kidney | 3 | 2023 | 1304 | 0.090 |
Why?
|
| Mice, Obese | 2 | 2021 | 73 | 0.080 |
Why?
|
| Glomerular Filtration Rate | 2 | 2020 | 564 | 0.060 |
Why?
|
| Chromosome Segregation | 1 | 2025 | 71 | 0.060 |
Why?
|
| Cell Differentiation | 2 | 2022 | 1944 | 0.050 |
Why?
|
| Humans | 7 | 2025 | 131501 | 0.050 |
Why?
|
| Butyrates | 1 | 2023 | 41 | 0.050 |
Why?
|
| Disease Progression | 2 | 2020 | 2205 | 0.050 |
Why?
|
| Glycyrrhizic Acid | 1 | 2023 | 3 | 0.050 |
Why?
|
| Interleukin-18 | 1 | 2023 | 78 | 0.050 |
Why?
|
| Chromatin | 1 | 2025 | 491 | 0.050 |
Why?
|
| Inflammasomes | 1 | 2023 | 156 | 0.040 |
Why?
|
| Regeneration | 1 | 2023 | 230 | 0.040 |
Why?
|
| Cell Death | 1 | 2021 | 237 | 0.040 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2020 | 59 | 0.040 |
Why?
|
| Epigenomics | 1 | 2021 | 186 | 0.040 |
Why?
|
| Lipocalin-2 | 1 | 2019 | 28 | 0.040 |
Why?
|
| Inflammation | 1 | 2026 | 1490 | 0.040 |
Why?
|
| Random Allocation | 1 | 2019 | 421 | 0.040 |
Why?
|
| Nephrectomy | 1 | 2019 | 174 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2023 | 804 | 0.030 |
Why?
|
| Collagen | 1 | 2019 | 289 | 0.030 |
Why?
|
| Actins | 1 | 2019 | 317 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2020 | 1168 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2026 | 4762 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 2019 | 810 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2021 | 1831 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2019 | 2567 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2021 | 4674 | 0.020 |
Why?
|
| Male | 2 | 2026 | 65158 | 0.020 |
Why?
|
| Risk Factors | 1 | 2021 | 10952 | 0.020 |
Why?
|